Dr. Farokhzad has co-founded multiple companies to translate his research into practical applications. These include BIND Therapeutics, which focuses on developing targeted therapeutic nanoparticles, and Selecta Biosciences, which aims to create targeted immunotherapies. His work has earned him numerous awards, including the prestigious Ernst & Young Entrepreneur of the Year Award.
